Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Biotech pros' top 8 stock picks
Fortune
Mon, 03/9/15 - 11:59 am
Tags:
biotech, Bluebird Bio, Chimerix, Puma Biotechnology, Incyte, Isis Pharmaceuticals, Celgene, Alexion, Regeneron
The Top 10 Biotech Companies In The U.S.
Forbes
Fri, 03/6/15 - 11:43 am
Tags:
biotech, Gilead Sciences, Amgen, Celgene, Biogen Idec, Regeneron, Alexion, Vertex Pharmaceuticals, Illumina, Biomarin, Agilent
Exclusive: Regeneron, Sanofi outline promising PhIIb data for top blockbuster pick dupilumab
Fierce Biotech
Mon, 02/23/15 - 08:47 am
Tags:
Sanofi, Regeneron, dupilumab, PCSK9 inhibitors
Regeneron Beats Genentech In Rare Face Off Over Diabetes-Related Vision Loss
Forbes
Thu, 02/19/15 - 10:38 am
Tags:
Regeneron, Genentech, diabetes, Eylea, Lucentis, DME, diabetic macular edema
3 Upcoming FDA Decisions We're Most Excited About
Motley Fool
Mon, 02/16/15 - 12:00 pm
Tags:
FDA, Celgene, Revlimid, Multiple Myeloma, Regeneron, Eylea, Vertex Pharmaceuticals, Kalydeco, lumacaftor
Why Regeneron's Risk-Reward Looks Good Again
Seeking Alpha
Fri, 02/13/15 - 09:08 am
Tags:
Regeneron
Regeneron says its allergy drug could be as big as PCSK9 blockers
Fierce Pharma
Wed, 02/11/15 - 05:40 pm
Tags:
Regeneron, allergies, Sanofi, dupilumab
Regeneron revenue beats Street on strong Eylea sales
Yahoo/Reuters
Tue, 02/10/15 - 08:45 am
Tags:
Regeneron, earnings
How Regeneron Pharmaceuticals, Sanofi, And Amgen Will Weather The Inevitable Price Wars
Seeking Alpha
Wed, 02/4/15 - 01:18 pm
Tags:
Regeneron, Sanofi, Amgen, drug pricing
This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
Motley Fool
Mon, 02/2/15 - 10:08 am
Tags:
Ophthotech, Novartis, Regeneron, Fovista, Roche, Avastin, Eylea, Lucentis, wet age-related macular degeneration
Drugmakers receive mysterious invites to White House
CNBC
Wed, 01/28/15 - 08:00 pm
Tags:
R&D, personalized medicine, Obama, Merck, Regeneron, Vertex Pharmaceuticals
Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug Race
Bloomberg
Mon, 01/26/15 - 08:08 am
Tags:
Sanofi, Regeneron, Amgen, alirocumab, evolocumab, PCSK9 inhibitors
Benefits firms shouldn't play drug favorites: CEO
CNBC
Tue, 01/20/15 - 09:12 am
Tags:
PBMs, Regeneron, Leonard Schleifer, Express Scripts
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Tags:
Harvoni, Viekira Pak, Gilead Sciences, AbbVie, alirocumab, evolocumab, Amgen, Regeneron, Sanofi, Opdivo, Keytruda, Merck, Bristol-Myers Squibb, Novartis, CTL019, Zarxio, Pfizer, palbociclib, Saxenda, Trulicity, Afrezza, MannKind, Eli Lilly, Novo Nordisk, LCZ696, Toujeo, Breo Ellipta, GED-0301, Celgene, BiogenIdec
After Roiling Hepatitis Market, Express Scripts Turns to Cholesterol
Bloomberg
Wed, 01/14/15 - 10:08 am
Tags:
hepatitis C, Express Scripts, Regeneron, Amgen, PCSK9 inhibitor
Express Scripts CEO: Amgen, Regeneron Among Targets for Drug Discounting
TheStreet.com
Tue, 01/13/15 - 04:46 pm
Tags:
Express Scripts, drug pricing, Amgen, Regeneron
Sanofi, Regeneron cholesterol drug also effective in monthly doses
Yahoo/Reuters
Fri, 01/9/15 - 08:03 am
Tags:
Sanofi, Regeneron, alirocumab
5 Potential Blockbuster Drugs Set To Launch In 2015
Investors.com
Thu, 01/8/15 - 08:15 am
Tags:
Amgen, Regeneron, evolocumab, alirocumab, Alexion, asfotase alfa, Novartis, LCZ696, Pfizer, palbociclib
Where Are They Now? A Look Back at the Best & Worst Biotech CEOs
TheStreet.com
Tue, 12/16/14 - 12:06 pm
Tags:
biotech, Vertex Pharmaceuticals, Myriad Genetics, Dendreon, Celgene, Regeneron
FDA to Review Eylea for Diabetic Retinopathy
Monthly Prescribing Reference
Mon, 12/1/14 - 10:36 am
Tags:
FDA, Eylea, diabetic retinopathy, Regeneron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.